Stay updated on GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page’s footer release/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software update without changing the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T17:17:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-17T13:42:47.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now live, replacing v3.4.3. No study content, eligibility criteria, or trial results are affected.
    Difference
    0.0%
    Check dated 2026-03-19T22:20:38.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T19:28:36.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.0%
    Check dated 2026-02-12T02:15:48.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no study data or page content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T12:18:18.000Z thumbnail image

Stay in the know with updates to GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.